Individual data points are shown as empty circles in all bar graphs.
-/-mice treated with or without tamoxifen. Note amplification of c-Fos deletion specific PCR product (280 bp) by primer P1 and P3 (shown below in a cartoon representation) after tamoxifen treatment, while non-deleted PCR product (0.4 kb) amplified by P1 and P2 are present before or non-tamoxifen treated mice. These mice were monitored for six months after tamoxifen injection and deletion specific PCR were performed periodically that showed persistent presence of Fos deleted cells. Mice were sacrificed after six months, and we did not observe any defect in blood and organs, suggesting that therapeutic targeting of these two genes will not have any adverse effect on normal tissues and organs. g. 
